Cross Immune Response Between Breast Carcinoma and Thyroid Autoimmunity: Impact on Prognosis and Treatment

You may be eligible if

• The study will include patients undergoing mammography (either for screening or for a suspect nodule) who meet all of the following criteria:
• signed informed consent
• age 18-80 years
• female sex
• Based on the mammography results and the outcome of any biopsy performed due to the presence of breast nodule(s), patients will subsequently be categorized into cases (diagnosed with breast cancer) and controls (not diagnosed with breast cancer).
• Pregnancy, within 6 months postpartum, and/or active breastfeeding
• Prior organ, bone marrow, or hematopoietic stem cell transplantation
• Prior splenectomy
• Therapy with biological agents, immunosuppressants, or immunomodulators
• History of breast cancer